JP2024543001A5 - - Google Patents
Info
- Publication number
- JP2024543001A5 JP2024543001A5 JP2024525372A JP2024525372A JP2024543001A5 JP 2024543001 A5 JP2024543001 A5 JP 2024543001A5 JP 2024525372 A JP2024525372 A JP 2024525372A JP 2024525372 A JP2024525372 A JP 2024525372A JP 2024543001 A5 JP2024543001 A5 JP 2024543001A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- acid construct
- sequence
- viral vector
- stxbp1
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163263175P | 2021-10-28 | 2021-10-28 | |
| US63/263,175 | 2021-10-28 | ||
| PCT/EP2022/080020 WO2023073071A1 (en) | 2021-10-28 | 2022-10-26 | Nucleic acid constructs, viral vectors and viral particles |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024543001A JP2024543001A (ja) | 2024-11-19 |
| JP2024543001A5 true JP2024543001A5 (https=) | 2025-10-31 |
Family
ID=84362196
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024525372A Pending JP2024543001A (ja) | 2021-10-28 | 2022-10-26 | 核酸構築物、ウイルスベクターおよびウイルス粒子 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20240417434A1 (https=) |
| EP (1) | EP4423286A1 (https=) |
| JP (1) | JP2024543001A (https=) |
| KR (1) | KR20240099360A (https=) |
| CN (1) | CN118434876A (https=) |
| AR (1) | AR127455A1 (https=) |
| AU (1) | AU2022378524A1 (https=) |
| CA (1) | CA3234666A1 (https=) |
| CL (1) | CL2024001100A1 (https=) |
| CO (1) | CO2024005920A2 (https=) |
| IL (1) | IL312340A (https=) |
| MX (1) | MX2024005171A (https=) |
| TW (1) | TW202325849A (https=) |
| WO (1) | WO2023073071A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025122543A1 (en) * | 2023-12-05 | 2025-06-12 | Voyager Therapeutics, Inc. | Compositions and methods for the treatment of disorders related to syntaxin-binding protein 1 deficiency |
| WO2025213064A1 (en) * | 2024-04-05 | 2025-10-09 | Capsida Biotherapeutics, Inc. | Gene therapy for stxbp1 encephalopathy |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5139941A (en) | 1985-10-31 | 1992-08-18 | University Of Florida Research Foundation, Inc. | AAV transduction vectors |
| AU8200191A (en) | 1990-07-09 | 1992-02-04 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | High efficiency packaging of mutant adeno-associated virus using amber suppressions |
| US5173414A (en) | 1990-10-30 | 1992-12-22 | Applied Immune Sciences, Inc. | Production of recombinant adeno-associated virus vectors |
| DE69233013T2 (de) | 1991-08-20 | 2004-03-04 | The Government Of The United States Of America As Represented By The Secretary Of National Institute Of Health, Office Of Technology Transfer | Adenovirus vermittelter gentransfer in den gastrointestinaltrakt |
| EP1103610A1 (en) | 1999-11-26 | 2001-05-30 | Introgene B.V. | Production of vaccines from immortalised mammalian cell lines |
| FR2808803B1 (fr) | 2000-05-11 | 2004-12-10 | Agronomique Inst Nat Rech | Cellules es modifiees et gene specifique de cellules es |
| FR2836924B1 (fr) | 2002-03-08 | 2005-01-14 | Vivalis | Lignees de cellules aviaires utiles pour la production de substances d'interet |
| EP1528101A1 (en) | 2003-11-03 | 2005-05-04 | ProBioGen AG | Immortalized avian cell lines for virus production |
| FR2884255B1 (fr) | 2005-04-11 | 2010-11-05 | Vivalis | Utilisation de lignees de cellules souches aviaires ebx pour la production de vaccin contre la grippe |
| EP1985305A1 (en) | 2007-04-24 | 2008-10-29 | Vivalis | Duck embryonic derived stem cell lines for the production of viral vaccines |
| EP1995309A1 (en) | 2007-05-21 | 2008-11-26 | Vivalis | Recombinant protein production in avian EBx® cells |
| JP5608863B2 (ja) * | 2007-12-28 | 2014-10-15 | 公立大学法人横浜市立大学 | 新生児期〜乳児期発症の難治性てんかんの検出方法 |
| EP2321417B1 (en) * | 2008-08-20 | 2015-07-15 | Brainco Biopharma, S.L. | Stxbp1 as psychiatric biomarker in murine model system and its uses |
| GB201403684D0 (en) | 2014-03-03 | 2014-04-16 | King S College London | Vector |
| MX2019011772A (es) * | 2017-04-03 | 2020-01-09 | Encoded Therapeutics Inc | Expresion transgenica selectiva de tejidos. |
| KR20220094216A (ko) * | 2019-11-08 | 2022-07-05 | 코브 테라퓨틱스 | 변형된 아데노-관련 바이러스 벡터 및 이의 중추신경계로의 전달 |
| US20230265453A1 (en) * | 2020-07-08 | 2023-08-24 | Baylor College Of Medicine | Gene therapy for stxbp1 encephalopathy |
| WO2022214635A1 (en) * | 2021-04-08 | 2022-10-13 | Stichting Vu | Nucleic acid molecules for compensation of stxbp1 haploinsufficiency and their use in the treatment of stxbp1-related disorders |
-
2022
- 2022-10-26 EP EP22812524.1A patent/EP4423286A1/en active Pending
- 2022-10-26 WO PCT/EP2022/080020 patent/WO2023073071A1/en not_active Ceased
- 2022-10-26 MX MX2024005171A patent/MX2024005171A/es unknown
- 2022-10-26 CN CN202280078693.9A patent/CN118434876A/zh active Pending
- 2022-10-26 AU AU2022378524A patent/AU2022378524A1/en active Pending
- 2022-10-26 AR ARP220102900A patent/AR127455A1/es not_active Application Discontinuation
- 2022-10-26 KR KR1020247017747A patent/KR20240099360A/ko active Pending
- 2022-10-26 CA CA3234666A patent/CA3234666A1/en active Pending
- 2022-10-26 US US18/704,867 patent/US20240417434A1/en active Pending
- 2022-10-26 JP JP2024525372A patent/JP2024543001A/ja active Pending
- 2022-10-26 IL IL312340A patent/IL312340A/en unknown
- 2022-10-28 TW TW111140997A patent/TW202325849A/zh unknown
-
2024
- 2024-04-11 CL CL2024001100A patent/CL2024001100A1/es unknown
- 2024-05-07 CO CONC2024/0005920A patent/CO2024005920A2/es unknown